Early Diagnosing and Treatment of Rheumatoid Arthritis, Benefits of Anti-Citrullinated Peptides Examination
By:
References
- 1. van Steenberger HW, Ajeganova S, Forslind K, Swensson B, van der Helm-van Mil AHM. The Effect of Rheumatoid Factor and Anticitrullinated Peptide Antibodies on Bone Erosions in Rheumatoid Arthritis. Ann Rheum Dis 2015; e3: 74.10.1136/annrheumdis-2014-206623
- 2. Britsemmer K, Ursum J, Gerritsen M, van Tuyl L, van Schaardenburg D. Validation of the 2010 ACR/EULAR Criteria for Rheumatoid Arthritis: Slight Improvement Over 1987 ACR Criteria. Ann Rheum Dis 2011; 70(8): 1468-70.10.1136/ard.2010.148619
- 3. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Hejde D. Treating Rheumatoid Arthritis to Target: Recommendations of an International Task Force. Ann Rheum Dis 2010; 69(4): 631-7.10.1136/ard.2009.123919
- 4. Kaneko Y, Kuwana M, Kameda H, Takeuchi T. Sensitivity and Specificity of 2010 Rheumatoid Arthritis Classification Criteria. Rheumatology(Oxford) 2011; 50(7): 1268-74.10.1093/rheumatology/keq442
- 5. Willemze A, Trouw LA, Toes RE, Huizinga TW. The Influence of ACPA Status and Characteristics on the Course of RA. Nat Rev Rheumatol 2012; 8(3): 144-52.10.1038/nrrheum.2011.204
Language: English
Page range: 28 - 31
Submitted on: Mar 27, 2017
Accepted on: Apr 20, 2017
Published on: Sep 30, 2017
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2017 Gabriela Belakova, V. Manka, E. Zanova, P. Racay, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.